Mouse spermatogenesis genes, human male sterility-associated genes and diagnostic system using the same
CA 2476561 A1 · Owner: Tanaka, Hiromitsu · Inventors: Tanaka, Hiromitsu; Nozaki, Masami; Nishimune, Yoshitake
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
It is intended to provide mouse spermatogenesis genes constituting a mass of 89 genes cDNAs synthesized from mRNAs of which respectively have the base sequences represented by SEQ ID NOS:1 to 89; an Scot-t gene variant and a protamine-2 gene variant which are human homologs of genes belonging to the above gene mass and associated with human male sterility; a mass of mouse spermatogenesis genes and various molecular biological materials relating thereto; various molecular biological materials relating to male sterilityassociated gene variants; and various test methods and diagnostic methods using the same.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 14, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 14, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 14, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.